Mustang Bio (MBIO) Competitors $1.87 +0.17 (+10.00%) Closing price 08/13/2025 04:00 PM EasternExtended Trading$1.87 +0.00 (+0.05%) As of 06:51 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBIO vs. DYAI, MAAQ, GBIO, OKUR, MURA, TPST, MDCX, BDRX, RNTX, and NNVCShould you be buying Mustang Bio stock or one of its competitors? The main competitors of Mustang Bio include Dyadic International (DYAI), Mana Capital Acquisition (MAAQ), Generation Bio (GBIO), OnKure Therapeutics (OKUR), Mural Oncology (MURA), Tempest Therapeutics (TPST), Medicus Pharma (MDCX), Biodexa Pharmaceuticals (BDRX), Rein Therapeutics (RNTX), and NanoViricides (NNVC). These companies are all part of the "pharmaceutical products" industry. Mustang Bio vs. Its Competitors Dyadic International Mana Capital Acquisition Generation Bio OnKure Therapeutics Mural Oncology Tempest Therapeutics Medicus Pharma Biodexa Pharmaceuticals Rein Therapeutics NanoViricides Dyadic International (NASDAQ:DYAI) and Mustang Bio (NASDAQ:MBIO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings. Does the media refer more to DYAI or MBIO? In the previous week, Dyadic International had 6 more articles in the media than Mustang Bio. MarketBeat recorded 8 mentions for Dyadic International and 2 mentions for Mustang Bio. Mustang Bio's average media sentiment score of 1.63 beat Dyadic International's score of 0.63 indicating that Mustang Bio is being referred to more favorably in the news media. Company Overall Sentiment Dyadic International Positive Mustang Bio Very Positive Which has better earnings and valuation, DYAI or MBIO? Dyadic International has higher revenue and earnings than Mustang Bio. Dyadic International is trading at a lower price-to-earnings ratio than Mustang Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDyadic International$3.49M7.07-$5.81M-$0.20-4.10Mustang BioN/AN/A-$15.75M-$78.00-0.02 Which has more volatility & risk, DYAI or MBIO? Dyadic International has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Mustang Bio has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500. Do insiders and institutionals believe in DYAI or MBIO? 28.0% of Dyadic International shares are owned by institutional investors. Comparatively, 10.0% of Mustang Bio shares are owned by institutional investors. 29.5% of Dyadic International shares are owned by company insiders. Comparatively, 0.2% of Mustang Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is DYAI or MBIO more profitable? Mustang Bio has a net margin of 0.00% compared to Dyadic International's net margin of -163.94%. Mustang Bio's return on equity of 0.00% beat Dyadic International's return on equity.Company Net Margins Return on Equity Return on Assets Dyadic International-163.94% -233.69% -59.37% Mustang Bio N/A N/A -29.49% Do analysts prefer DYAI or MBIO? Dyadic International presently has a consensus price target of $6.00, indicating a potential upside of 631.71%. Given Dyadic International's stronger consensus rating and higher probable upside, research analysts clearly believe Dyadic International is more favorable than Mustang Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dyadic International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Mustang Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryDyadic International beats Mustang Bio on 9 of the 15 factors compared between the two stocks. Get Mustang Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for MBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBIO vs. The Competition Export to ExcelMetricMustang BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.44M$3.03B$5.54B$9.82BDividend YieldN/A2.27%4.62%4.12%P/E Ratio-0.0220.6730.1326.03Price / SalesN/A365.02462.16104.73Price / CashN/A42.0537.7558.93Price / Book2.837.638.496.06Net Income-$15.75M-$54.65M$3.26B$265.11M7 Day Performance23.03%5.41%4.19%3.38%1 Month Performance-22.73%7.14%4.65%2.28%1 Year Performance-88.67%31.27%35.15%29.67% Mustang Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBIOMustang Bio0.3987 of 5 stars$1.87+10.0%N/A-89.5%$7.44MN/A-0.02100Positive NewsEarnings ReportDYAIDyadic International3.1557 of 5 stars$0.81-13.6%$6.00+640.8%-39.3%$28.19M$3.49M-4.057News CoverageEarnings ReportMAAQMana Capital AcquisitionN/A$3.45-10.9%N/A+790.5%$28.03MN/A0.001High Trading VolumeGBIOGeneration Bio3.7699 of 5 stars$4.04-1.5%$80.00+1,880.2%-73.9%$27.62M$19.89M-0.37150News CoverageEarnings ReportAnalyst ForecastGap UpOKUROnKure Therapeutics3.2734 of 5 stars$2.03-0.5%$32.33+1,492.8%N/A$27.56MN/A-0.39N/AEarnings ReportGap UpMURAMural Oncology3.1658 of 5 stars$1.55-2.5%$12.00+674.2%-42.4%$27.55MN/A-0.18119Gap UpHigh Trading VolumeTPSTTempest Therapeutics3.092 of 5 stars$8.01+8.8%$30.00+274.5%-34.7%$27.10MN/A-0.4520Positive NewsEarnings ReportMDCXMedicus Pharma2.0735 of 5 stars$1.97flat$23.50+1,092.9%N/A$26.74MN/A-1.70N/AEarnings ReportAnalyst ForecastBDRXBiodexa Pharmaceuticals0.2001 of 5 stars$6.89-3.4%N/AN/A$26.06M$470K0.0020Positive NewsRNTXRein TherapeuticsN/A$1.16+4.5%N/AN/A$25.58MN/A-0.419NNVCNanoViricides0.268 of 5 stars$1.54-2.5%N/A-13.8%$24.75MN/A-2.1420 Related Companies and Tools Related Companies DYAI Alternatives MAAQ Alternatives GBIO Alternatives OKUR Alternatives MURA Alternatives TPST Alternatives MDCX Alternatives BDRX Alternatives RNTX Alternatives NNVC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MBIO) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredAmericans are rushing into gold (but not billionaires!)Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mustang Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mustang Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.